《港樓》嘉里建設郭氏家族斥逾1.2億購灣仔兩舊樓物業
嘉里建設(00683.HK)郭氏家族成員,最新以共1.22億元購入灣仔皇后大道東兩幢舊樓物業,連同早前購入相鄰地盤,共作價約3.24億元。
最新成交物業包括皇后大道東98號全幢,成交價5,980萬元,買家為MORINDALE HOLDINGS LIMITED,公司股東為一間秘書公司,董事則包括嘉里集團創辦人郭鶴年兒子郭孔輔及相關人士。至於毗鄰的皇后大道東106及108號,則以6,220萬元售出,買家為ACACIA BAY HOLDINGS LIMITED,公司董事同為郭孔輔等。
資料顯示,郭氏家族早前已斥4,200萬元購入皇后大道東104號富東大廈,而去年則以1.6億元購入皇后大道東100及102號全幢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.